ReSound OMNIA RIE vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

ReSound OMNIA RIE
The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,498. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #31 of 39 devices in the prescription hearing aid category. This device shows notable strengths in speech clarity for quiet environments, scoring 3.7/5—a solid result that sits 0.34 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users who find their own voice bothersome in other devices. Feedback handling is strong in absolute terms at 4.1/5, though it falls 0.62 points below the category average of 4.72/5. The OMNIA RIE's most significant limitation is speech in noise performance, scoring just 1.0/5—a low result that trails the category average by 1.11 points. For users who frequently encounter challenging listening environments like restaurants or group conversations, this represents a meaningful gap compared to alternatives. Music streaming scores a mixed 2.7/5, essentially matching the category average. The device offers flexible power options with both rechargeable and disposable batteries, plus streaming compatibility with iPhone and Android devices including hands-free functionality. However, at this premium price point, several competitors deliver stronger overall performance, including options from Phonak, Oticon, and Widex. The OMNIA RIE may suit users who prioritize quiet-environment clarity and own-voice comfort over noise-handling capabilities.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit